Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
100.84%
operating margin TTM
48.39%
revenue TTM
156.93 Million
revenue per share TTM
1.22$
valuation ratios | |
|---|---|
| pe ratio | 6.83 |
| peg ratio | 0.02 |
| price to book ratio | 3.41 |
| price to sales ratio | 6.66 |
| enterprise value multiple | 11.65 |
| price fair value | 3.41 |
profitability ratios | |
|---|---|
| gross profit margin | 90.36% |
| operating profit margin | 48.39% |
| pretax profit margin | 51.48% |
| net profit margin | 100.84% |
| return on assets | 39.65% |
| return on equity | 59.0% |
| return on capital employed | 21.77% |
liquidity ratios | |
|---|---|
| current ratio | 5.42 |
| quick ratio | 4.97 |
| cash ratio | 1.80 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 548.68 |
| operating cycle | 596.88 |
| days of payables outstanding | 21.08 |
| cash conversion cycle | 575.80 |
| receivables turnover | 7.57 |
| payables turnover | 17.31 |
| inventory turnover | 0.67 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.10 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.09 |
| interest coverage | 17.79 |
| cash flow to debt ratio | 2.88 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.33 |
| cash per share | 3.41 |
| operating cash flow per share | 1.34 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 2.88 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 1,000.95 |
Frequently Asked Questions
When was the last time Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reported earnings?
Aurinia Pharmaceuticals Inc. (AUPH) published its most recent earnings results on 06-08-2026.
What is Aurinia Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)'s trailing twelve months ROE is 59.0%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Aurinia Pharmaceuticals Inc. (AUPH) currently has a ROA of 39.65%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AUPH's net profit margin stand at?
AUPH reported a profit margin of 100.84% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AUPH's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.42 in the most recent quarter. The quick ratio stood at 4.97, with a Debt/Eq ratio of 0.10.